Ashley Dalton MP: speeches

Speeches

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  I commend my hon. Friend for the campaigning that he has done in his brother’s name in the area of rare and less survivable cancers, including brain tumours. We are putting patients at the centre of this plan, which says not only that every patient will have a personalised cancer treatment plan, but that patients will be at the heart of deciding those plans. Alongside their clinicians, they will have a role to play in deciding what treatment works for them. I know personally what that means. When I got my diagnosis, the immediate suggestion was that I would have intravenous chemotherapy. I was able to engage with my oncologist and say, “I’m not sure that that works for my lifestyle. I want to be able to live my life.” We were able to work together to find the right treatment that fits in with my lifestyle, and which allows me to come to work and do this job. That is what we want for every single cancer patient in this country. Their treatment should be about not just keeping them alive, but extending and maintaining their quality of life.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  Harnessing technology right across the cancer landscape is what this plan is about. Where it is appropriate for less invasive treatments to be used, we are looking to explore how we can roll them out across the country, regardless of postcodes. Lots more people are surviving cancer with treatment, but what is important is that the side effects of invasive cancer treatment can be significant—I know: I have several of them—so, where possible, we want to use innovative, less invasive treatments so that people can live longer, more fruitful and less painful lives.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  Yes, we are aware of that. We are looking at the existing metrics and at what we can do to improve them to ensure that they are actually making a difference to people’s outcomes.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  As my hon. Friend knows—I do not need to tell him this—brain tumours, leukaemia and other less stageable cancers cannot be assessed in the usual way, so we need different measures to understand how early they are being caught. That is why this plan commits to the regular publication of data on emergency cancer diagnoses as a key indicator, exposing where these cancers are picked up too late so that we can drive earlier detection and focus attention where it is most urgently needed.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  I thank my hon. Friend for his question. Lung cancer has impacted on my family as well. Yes, we will be rolling out lung cancer screening nationwide by 2030, because we know that it has a huge impact on outcomes. I have seen how amazing the AI tools are at identifying discrepancies in lung CT scans. I found out that I had an untapped talent, as I was quite good at identifying those discrepancies as well. AI means that we can catch lung cancers sooner. They are often not caught until they are at stage 3 or 4. Using AI means that we can get them at stage 1 or 2, we can treat people early and we can save lives.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  The trust to which the right hon. Gentleman refers is the trust where I had my primary cancer treatment, so I am acutely aware of the challenges. We have set a really clear and simple ambition: to get cancer patients the timely care they need, and to meet all waiting time standards by the end of this Parliament. That means that by March 2029, 80% of patients will get a diagnosis or the all-clear within 28 days, and 85% of patients will start their treatment within 62 days of referral. Some people have asked me why the figure is not 100%. It is not possible to make it 100%, because not everybody’s cancer is simple or easy to identify, and sometimes it takes longer. We want to ensure that the only reason for delays beyond 62 days is the complexity or specifics of someone’s cancer, not the inability of a trust to meet the targets. We are going to cut waiting times by giving trusts and cancer alliances detailed practical information and granular data on individual cancer types so that we can highlight real-time pathway insights through a federated data platform, and by streamlining the cancer metrics so that we can shine a light on unwarranted variation in care. We are providing information and best practice, thereby taking the best of the NHS to the rest of the NHS. We are linking up professionals and clinicians across the UK, so that they can share their best practice. Trusts can help and support each other to reach the targets.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  I offer the hon. Member my deepest condolences on the news that she has shared with the House. I share her concern that we have to reach others. Some less survivable cancers can be tackled if they are caught early, and we have specifically committed in the plan to reducing significantly the number of rare and less survivable cancers that are diagnosed in an emergency setting, which she described as happening to her family. Primary care is where most people first raise concerns. GPs rarely see rare cancers, because they are rare, so we are rolling out AI-driven decision support tools to help GPs think cancer sooner, think cancer earlier and make decisions about referral more quickly.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  We are learning from comparable countries. By looking at what they have achieved, we have begun to put together this plan. We want to make Britain the place to come to for clinical trials of new innovative treatments. We are looking not only to learn from other countries about the treatments they already offer, but to have our own home-grown new treatments and innovations through our clinical trials accelerator in the UK.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  I thank my hon. Friend for his question and offer my condolences on the loss of his Auntie Hillary. Yes, this plan is designed to ensure that an extra 320,000 people at the end of the course of the plan will have had their lives saved or be living well with cancer after their five-year diagnosis. We want to make sure that everybody gets that opportunity, regardless of where they live.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  Ministers quite like making promises from the Dispatch Box on behalf of our Front-Bench colleagues, but in this case I think I will just gently encourage my right hon. Friend the Secretary of State to join the hon. Member, if he is able to do so—I look forward to seeing the photographs. We are exploring opportunities for breast cancer screening. There are difficulties in early screening because of dense breast tissue, but we are expanding screening where it provides support. In particular on breast screening, we are monitoring the emerging evidence from BRAID—breast screening risk adaptive imaging for density—trials, which target programmes at women with greater risk. We are also considering the findings from the £11 million EDITH—early detection using information technology in health—trial, testing how cutting-edge tools can be used to catch breast cancer cases earlier, particularly in younger women, like me, for whom a mammogram was not successful because of dense breast tissue.

• 5 Feb 2026 · National Cancer Plan · Hansard source

  More

  Through the spending review, providers have been allocated £15 billion in operational capital for local priorities and £5 billion to support the return to constitutional standards on radiotherapy. Responsibility for purchasing new machines sits at local level, and we expect local systems to continue to invest in new machines to meet the ambitious targets and to meet their local needs.

• 13 Jan 2026 · Topical Questions · Hansard source

  More

  Local authorities must assess disabled children’s social care needs and provide respite care, including funding short breaks where appropriate. We are currently developing an all-age palliative care and end-of-life care modern service framework, and will consider the issue of emotional and practical support, including for parents who are carers, as part of that work. My hon. Friend the Minister for Care chairs a cross-Government meeting with Ministers from the Departments for Work and Pensions, for Business and Trade and for Education, to consider how we can provide care as we improve recognition and support. I would be happy to meet my hon. Friend and the founder of Harry’s Pals.

• 13 Jan 2026 · Brain Cancer Treatment: Hartlepool · Hansard source

  More

  As my hon. Friend rightly points out, I was privileged to answer for the Government in the Westminster Hall debate last week on this very issue, and I vividly remember Trevor’s story. Last week, I did commit to exploring current arrangements for tissue freezing options and the options for change, and I recommit to doing that today. I would be more than happy to meet him and his constituent to discuss this further.

• 13 Jan 2026 · Brain Cancer Treatment: Hartlepool · Hansard source

  More

  As previously stated, we are boosting investment to unlock new treatments and improve outcomes for brain cancer patients, including investing in cutting-edge equipment to improve access to samples for research. Each pathology service in England maintains its own standard procedures for tissue freezing, which inform local capabilities and practices, and we are investing in England’s pathology networks to deliver productivity and transformation improvements.

• 13 Jan 2026 · ADHD Services · Hansard source

  More

  As it is the ICB shared by my constituency, I am equally concerned. This will be explored as part of the review and I am more than happy to ask the Minister responsible to contact the hon. Gentleman further on how we can take that forward.

• 13 Jan 2026 · ADHD Services · Hansard source

  More

  Through the medium-term planning framework, which we published in October 2025, we set out those expectations. We will continue to work with trusts to develop them to make sure that people with ADHD, or suspected ADHD, get the support they need. I am more than happy to meet the APPG to discuss these matters further.

• 13 Jan 2026 · ADHD Services · Hansard source

  More

  We know that many people with suspected ADHD—attention deficit hyperactivity disorder—experience severe delays in accessing assessments. That is not right. We want people with ADHD to receive the right support in their communities. Our medium-term planning framework sets out expectations for local areas to improve access to ADHD services. The independent review into prevalence and support for mental health conditions, ADHD and autism will work with people with lived experience to identify challenges and solutions. The final report is due to be published in summer and will build on the independent ADHD taskforce report, which we welcome.

• 13 Jan 2026 · Brain Cancer Treatment: Washington and Gateshead South · Hansard source

  More

  We are determined to ensure that everyone who receives a brain tumour diagnosis, regardless of where they live, has access to the latest treatment options. I look forward to meeting Owain’s wife, Ellie, later this month to hear more about their story and the next steps on this topic.

• 13 Jan 2026 · Brain Cancer Treatment: Washington and Gateshead South · Hansard source

  More

  I also put on record my condolences to the family and friends of Colin Pickthall, the former Member for West Lancashire. As the current Member for that seat, it is my privilege to build on his legacy. We are committed to furthering investment to unlock new treatments and improve outcomes for brain cancer patients, including by investing in cutting-edge equipment to improve access to samples for research. Individual pathology services in England maintain their own standard operating procedures, and they outline local capabilities and practices, but we are continuing to invest in England’s pathology networks to deliver productivity and transformation improvements.

• 7 Jan 2026 · Advanced Brain Cancer: Tissue Freezing · Hansard source

  More

  I am happy to confirm that I will ask officials to look into that, and to give me some advice on that pilot and on having a conversation with those running it about what we could learn from them. I thank the hon. Member for raising that question. I will close by paying tribute to our late colleague and Member of the Senedd, Hefin David. Through tireless campaigning, he brought Owain’s story to the Senedd. My hon. Friend the Member for Caerphilly has now brought it to this place and I thank him for that. I look forward to working with him and other hon. Members to make 2026 the year that we shift the dial for patients with brain cancer.

• 7 Jan 2026 · Advanced Brain Cancer: Tissue Freezing · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Mr Western. I thank my hon. Friend the Member for Caerphilly (Chris Evans) and all other hon. Members for their contributions, many of which were deeply personal and moving. I thank them all for their courage and soft-heartedness, and for bringing such compassion and insight to this debate. Let me say how sorry I was to hear about the loss of Owain at the age of just 34. His story reminds us that many people lose their lives to brain cancer very shortly after diagnosis, and we are determined to do all we can to change that. I extend my deepest sympathies to his wife Ellie, who is here today, and his daughter Amelia. I would be honoured to meet Ellie and my hon. Friend to hear more about her and Owain’s story. Just yesterday, I was here for a debate on less survivable cancers. These debates and the petition show how much progress on cancer matters to Parliament and the public. My hon. Friend the Member for Mitcham and Morden (Dame Siobhain McDonagh) said that debates on brain cancer are a bit like buses: there are none for ages, then suddenly three at once. I want to acknowledge that her work has led to the higher profile for such debates in Parliament, more of which are taking place. I thank and commend her for her efforts in this field. My hon. Friend the Member for Caerphilly raised incredibly serious issues about how informed consent, tissue freezing and innovation are impacting patients. I will take those points in turn. I will primarily address the context in England, although I acknowledge that areas of this policy apply across the UK. On informed consent and tissue storage, as a cancer patient myself, I find it very troubling when patients say they have not been informed about their tissue storage, as campaigners have reported. I completely understand why the Owain’s law petition calls for people to be properly informed about the choices available to them. Let me be clear: patients must always be fully informed about their rights, options and choices regarding the storage and future use of their tissue samples. The Human Tissue Authority was established in 2004 to oversee and licence organisations in the removal, storage and use of human tissue in England, Wales and Northern Ireland. Under the Human Tissue (Quality and Safety for Human Application) Regulations 2007, consent must be sought to collect human tissues and cells that are to be used in patient treatment. The Human Tissue Authority ensures compliance against those regulations as part of its standards, inspection and licensing regime. Consent should be sought in line with the suitable treatment options available to individual patients, which would be determined by their clinicians. That requirement extends to the collection of tumour samples that are to be used as the starting material in the manufacture of cancer vaccines. The Government expect establishments to be held to the highest standards to ensure appropriate and ethical use of human tissue. I understand that my hon. Friend is meeting with the Human Tissue Authority to discuss this matter further, and I know that he will keep me closely in the loop on that. Owain’s law also asks for every NHS hospital to freeze suitable brain tumour tissue to allow patients to benefit from emerging cancer treatments. Individual pathology services in England have their own processes, known as standard operating procedures, for fresh freezing of tissue samples. NHS procedures mirror local capabilities, which means the capacity for fresh freezing often depends on the availability of neurosurgery services in the local area. The human tissue regulations were introduced due to concerns that pathologists were retaining human tissues without appropriate consent. Any changes will need to be carefully considered by the Government. However, as was requested by my hon. Friend the Member for Caerphilly and the hon. Member for Strangford (Jim Shannon), I am happy to liaise with the devolved Governments on this issue, and I commit today to further exploring the current arrangements for freezing tissues and the options for change, particularly for brain tumour tissues. Beyond improving access to emerging treatments through freezing, we know that the most effective way to improve survival rates from cancers, including brain cancers, is to catch them early. That is why we have agreed around £600 million of capital investment in diagnostics for this financial year. Over £100 million will go to histopathology services, automation and digital diagnostics to improve pathology laboratories.

• 7 Jan 2026 · Advanced Brain Cancer: Tissue Freezing · Hansard source

  More

  I note my hon. Friend’s clarification, but with that in mind, we do know that it is important to diagnose all cancers as quickly as possible, and the diagnosis of brain cancers is equally important so as to start treatment as quickly as possible. To that end, the Chancellor announced further investment in diagnostics at the autumn statement as part of a £6 billion capital investment to deliver constitutional standards. On genomics, I met the chief scientific officer for genomics yesterday to discuss how we ensure that the UK remains a world leader in genomics—which we are—and that we can apply genomics to improve cancer outcomes. We hope that our investment in diagnostics and pathology will mean that, in future, patients such as Owain will access a greater range of treatment options. My hon. Friend the Member for Caerphilly and Ellie are entirely right to raise the importance of innovation, particularly for less survivable cancers such as brain cancer. The Government are proud to support the Rare Cancers Bill introduced by my hon. Friend the Member for Edinburgh South West (Dr Arthur). Next Friday, Baroness Elliott will move its Second Reading in the other place. We will go even further to ensure that all patients with brain cancer have access to cutting edge clinical trials, innovation and lifesaving treatments. As part of our action, the National Institute for Health and Care Research announced the pioneering brain tumour research consortium to accelerate research into new brain tumour treatments across the UK. The NIHR is backing the consortium with an initial £13.7 million and more money to come this year. The world-leading consortium aims to transform outcomes for adults and children who are living with brain tumours and for their families, ultimately reducing the number of lives lost to cancer. As I confirmed yesterday, I will write to my hon. Friend the Member for Mitcham and Morden in detail regarding access to funding. I am happy to commit to seeking information and exploring how we can make access to funding much clearer and more transparent. I am pleased to confirm that the national cancer plan for England will be published in just a few short weeks, in early February. It will focus on rarer cancers, including brain cancer, and will include further details on how we will improve outcomes and work with stakeholders such as the Tessa Jowell Brain Cancer Mission to do so. The plan will detail further action to speed up diagnosis and treatment in England, ensuring that patients have access to the latest treatments and technology and ultimately driving up survival rates.

• 6 Jan 2026 · Therapeutic Play and Children’s Healthcare · Hansard source

  More

  As I stated earlier, we are promoting the Play Well toolkit right across the country through a variety of communication methods. We look forward to a variety of healthcare settings using that toolkit to deliver in their local areas. That moves me on to mental health. Under this Government, all children will have access to a mental health support team in their school or college by the end of this Parliament. We are also committed to opening 50 Young Futures hubs over the next four years, which will bring together services to help young people at a community level. There have been calls for us to go further on the children’s health workforce. The Minister for Secondary Care, my hon. Friend the Member for Bristol South (Karin Smyth), is absolutely committed to making sure that we have the right skills to care for patients, including children, when they need it. We are working through the changes and what they will mean for different professional groups. I know that mental health will be at the top of the agenda, not least for children. Health play therapists are trained through foundation degrees. The toolkit that has been developed sets out clearly how services should support practical training of specialists. Games and active play build social and emotional skills and support children’s wellbeing. We want every child to feel safe from harm and for their families to feel supported. We know that the poorest children are more likely to develop long-term illnesses. That is why it is shameful that child poverty has increased by 700,000 since 2010. With more than 4 million children now living in poverty in the UK and 800,000 children using food banks to eat, my right hon. Friend the Chancellor took the necessary decision to fund the biggest reduction in child poverty of any Budget this century. We are expanding free school meals to half a million kids whose parents are on low incomes, and lifting hundreds of thousands out of poverty by removing the two-child benefit cap. In addition, there is a £126 million funding boost for the family hubs and Start for Life programme this financial year. Best Start family hubs will be rolled out to every local authority from April. We have kept our manifesto promise to restrict junk food advertising targeted at children. We have announced improvements to the soft drink industry levy, and we have invested £11 million in local authorities to deploy supervised toothbrushing for three to five-year-olds in schools and nurseries in the most deprived areas of England. On neighbourhood health, my hon. Friend the Member for Leyton and Wanstead raised an important point about multidisciplinary teams for children and young people, which should take an holistic approach to looking after children. The aim is to embed general paediatricians in primary care to give specialist paediatric advice and reduce the need for out-patient paediatric referrals. Those discussions ideally bring together wider health, social care and educational specialists. The make-up of the teams is locally determined by integrated care boards, but play specialists could absolutely be involved as part of a neighbourhood team.

• 6 Jan 2026 · Therapeutic Play and Children’s Healthcare · Hansard source

  More

  As my hon. Friend will have noticed, I referred to the workforce plan. My hon. Friend the Minister for Secondary Care will consider all areas of the workforce and what should be included. Play specialists could be involved; their use is most appropriate in teams that give face-to-face patient care, for example when a GP and a paediatrician hold a joint clinic in a GP practice. The majority of case discussions are held virtually, without the patient or family in attendance. There is probably less need for play specialists to support children in those circumstances, but we do encourage the use of the Play Well kit, to ensure that children’s needs are taken into consideration throughout the healthcare process. For the first time, in the recently published guidance, we require NHS providers to consider children in the roll-out of all services. The Government are cutting waiting lists, giving children a healthier start in life and lifting half a million children out of poverty. This year—2026—will be critical, as we roll out the Best Start in Life hubs to every local authority in April, while rolling out neighbourhood health hubs and implementing the 10-year plan. The Government fundamentally believe in the importance of play. I am sure all my right hon. and hon. Friends would agree that we could do with a little bit more play in our lives, including in this place. As my hon. Friend the Member for Stroud (Dr Opher) pointed out, all play is therapeutic, and we would all benefit from a little more play. I stand ready to work with NHS England, my hon. Friend the Member for Leyton and Wanstead and Starlight to make this a decisive year for children’s health. Question put and agreed to.

• 6 Jan 2026 · Therapeutic Play and Children’s Healthcare · Hansard source

  More

  It is a pleasure to serve under your chairship, Mrs Harris. I thank my hon. Friend the Member for Leyton and Wanstead (Mr Bailey) for securing this debate on such an important topic. I am grateful to him for sharing Hari’s story, and to Hari and Sarah for making the trip to Parliament. I have always believed in bringing patient voices to the heart of what we do in Parliament, and I hope they both leave safe in the knowledge that this Government are listening. I strongly agree with what hon. Friends have said about the relationship between play and medicine. I volunteered in a healthcare setting as a play worker many moons ago, but more than 30 years later, the important impact of that work has stayed with me. Play and medicine are not in competition, and it is disappointing that Sarah had to fight so hard for play to remain an essential part of Hari’s care. I am pleased that my hon. Friend the Member for Leyton and Wanstead got a constructive response from Whipps Cross, but he is right to say that coverage of play services varies across the country. Investing in our children is not just a moral mission; it is a downpayment on a better future. Children do not stop being children when they enter a hospital or a GP clinic. It is important to treat children like children when they are at home, at school or in hospital. There is growing evidence that therapeutic play can mitigate risks of trauma. We recognise that play services are integral to paediatric care, not a nice-to-have. We published the NHS England and Starlight Play Well toolkit in June last year, and I am delighted to see representatives of Starlight in the Public Gallery today. That included the first national guidelines and standards for commissioning and delivering health play services in England. NHS England is making sure that every manager of health play services knows about the Play Well toolkit across a wide range of settings. We are promoting it in community clinics, emergency departments, children’s hospices and acute paediatric wards. A range of communication channels have been used to raise awareness, including engagement with services via professional bodies, messaging via the chief nursing officer, and ongoing promotion through operational delivery networks directly to trusts and with professional groups. The NHS is also undertaking evidence-based initiatives such as the iSupport programme, which focuses on ensuring children’s rights and wellbeing. The iSupport checklist aims to help professionals deliver safe, compassionate and child-centred care. The programme is already being picked up by children’s wards across the country. I look forward to meeting Starlight. We have been trying to get this meeting in the diary for some time, and I am delighted that we have managed to do that. I look forward to working with Starlight to see where we can go further to help kids like Hari avoid childhood trauma.